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Abstract  21 
Campylobacter jejuni is a commensal bacterium in the intestines of animals and 22 
birds and a major cause of foodborne gastroenteritis in humans worldwide. Here we 23 
show that exposure to pancreatic amylase leads to secretion of an α-dextran by C. 24 
jejuni and that a secreted protease, Cj0511, is required. Exposure of C. jejuni to 25 
pancreatic amylase promotes biofilm formation in vitro, increases interaction with 26 
human epithelial cell lines, increases virulence in the Galleria mellonella infection 27 
model and promotes colonisation of the chicken ileum. We also show that exposure 28 
to pancreatic amylase protects C. jejuni from stress conditions in vitro suggesting 29 
that the induced α-dextran may be important during transmission between hosts. 30 
This is the first evidence that pancreatic amylase functions as an inter-kingdom 31 
signal in an enteric micro-organism.  32 
   33 
Introduction  34 
Campylobacter infection is a major cause of foodborne gastroenteritis in humans 35 
worldwide (1). Disease ranges from mild, non-inflammatory, self-limiting diarrhea to 36 
prolonged, inflammatory diarrhea and occasional serious complications such as 37 
Guillain-Barré syndrome and reactive arthritis (1). Ninety percent of human disease 38 
is attributed to C. jejuni, while Campylobacter coli accounts for the remainder (2).  39 
 In contrast to human infection, C. jejuni establishes a largely asymptomatic 40 
but persistent infection in animals and birds, and the major risk of human infection is 41 
from handling and consumption of poultry meat (3, 4, 5). Campylobacters primarily 42 
inhabit the lower gastrointestinal (GI) tract of poultry and contamination of the flesh 43 
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of the bird occurs at slaughter. Campylobacter spp. are present in the luminal crypts 44 
of the chicken gut as densely-packed communities surrounded by mucus (6), an 45 
arrangement suggestive of a biofilm, a structured community of bacteria enclosed in 46 
a self-produced exopolymeric matrix (EPM) composed primarily of polysaccharides 47 
(7). Biofilms have also been described on experimentally-infected human ileum ex 48 
vivo suggesting that this mode of growth is also important during human infection (8, 49 
9). 50 
 Despite several studies of C. jejuni biofilms (10-15), the EPM has not been 51 
characterised. Polysaccharide is a major component of most bacterial EPMs and 52 
provides the structural framework (7, 16, 17). C. jejuni produces several surface-53 
associated carbohydrate structures including lipooligosaccharide (LOS), capsular 54 
polysaccharide (CPS) and both N- and O-linked glycoproteins (18), but there is no 55 
evidence that these glycans contribute to biofilm formation (11, 19).  56 
 Enteric bacteria use environmental signals present in host environments to 57 
regulate the expression of components required for interaction with the host and 58 
signals include bile salts, mucus, low oxygen, bicarbonate and neuroendocrine 59 
stress hormones (20-22). C. jejuni shows increased interaction with intestinal 60 
epithelial cells (IECs) in response to low oxygen, bile salts and noradrenaline (23-61 
25). In addition, bile salts have recently been reported to enhance C. jejuni biofilm 62 
formation by causing release of extracellular DNA (26). 63 
 Here we show that C. jejuni responds to the presence of pancreatic amylase 64 
by secreting an α-dextran that is a component of the biofilm EPM. This is the first 65 
definitive characterisation of the polysaccharide component of C. jejuni biofilms.  66 
Importantly, pre-exposure to pancreatic amylase results in significant changes in the 67 
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interactions of C. jejuni with the host in both in-vitro and in-vivo infection models. 68 
Pre-exposure to pancreatic amylase also promotes stress tolerance in vitro 69 
suggesting that the α-dextran may be important during transmission. This is the first 70 
evidence that pancreatic amylase is used by an enteric micro-organism as a signal 71 
to regulate interaction with the host.  72 
 73 
MATERIALS AND METHODS 74 
Bacterial strains and growth conditions. Bacterial strains are listed in Table 1. C. 75 
jejuni was stored at -70ºC in Brucella broth (BB; Oxoid) containing 15% glycerol and 76 
was grown on Mueller Hinton agar (MHA; Oxoid), Brucella agar (BA; Oxoid), 77 
Columbia blood agar (CBA; Oxoid) containing 7% defibrinated horse blood (E & O 78 
Laboratories) in a microaerobic atmosphere generated using Campypaks (Oxoid) in 79 
gas jars at 37°C. Charcoal (0.4%) was added to BA to improve contrast for 80 
photography. For broth cultures, BB or Eagle’s Minimal Essential Medium-α (MEM-81 
α; Sigma-Aldrich, M0894) were used and incubated with shaking (50 rpm) at 37°C in 82 
5% CO2. Kanamycin (Km; 40 μg/ml) and chloramphenicol (Cm; 20 μg/ml) were used 83 
for selection.  84 
 85 
Sources of pancreatic amylase. Hog pancreatic α-amylase (HPA) was purchased 86 
from Sigma Aldrich. Polyhistidine-tagged human pancreatic amylase expressed and 87 
purified from human cells was obtained from Sino Biologicals. For chicken pancreas 88 
extract, 20 organs were homogenized in 0.05 M Tris, 0.9% NaCl, 0.05 M CaCl2, pH 89 
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8.0 (27). After centrifugation (1,000 x g, 20 min), amylase activity in the supernatant 90 
was quantified by enzymatic assay (28).  91 
 92 
EPM purification and characterisation. Growth (48 h) removed from MHA with or 93 
without 100 nM HPA was suspended in phosphate buffered saline (PBS) and the 94 
extracellular material was recovered using modifications of a method previously used 95 
to isolate exo-polysaccharide from Vibrio parahaemolyticus (29). Briefly, the bacterial 96 
cell suspensions in PBS were washed on a rotary platform at 200 rpm for 1.5 h at 97 
30ºC, vortexed for 15 min and washed again at 200 rpm for 1.5 h at 20ºC. The 98 
supernatant was recovered (1,800 x g, 15 min) and precipitated overnight with 4 99 
volumes of cold acetone at 4°C. The precipitate was recovered (450 x g, 5 min), 100 
washed in distilled water (dH2O), dried (Speedvac SPD1010, Thermo Scientific), 101 
dissolved in dH2O and stored at -70°C. Total carbohydrate was measured by phenol-102 
sulphuric acid assay (30) with glucose as standard. To determine the statistical 103 
significance, a one-way ANOVA was used to compare the amount of secreted 104 
carbohydrate in response to the seven different doses of pancreatic amylase. Within 105 
the one-way ANOVA we constructed two contrasts, the first compared the joint effect 106 
of the three lowest doses with the joint effect of the four highest doses, the second 107 
compared the effect of a dose of 50 nM pancreatic amylase with 100 nM.  As 108 
independent samples of a bacterial culture were exposed to the different doses of 109 
amylase in a closed system, we assumed independence between the seven 110 
experiments. To analyse the amount of carbohydrate secreted by the wild-type, 111 
Cj0511 mutant and complemented strain, a two-way ANOVA was performed 112 
comparing the amount of secreted carbohydrate in response to the four different 113 
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doses of pancreatic amylase in the three different strains. Contrasts of the 15 nM 114 
joint with 50 nM concentrations, versus 100 nM joint with 500 nM concentrations 115 
were constructed for C. jejuni 11168H, Cj0511 mutant, and complemented strains. 116 
Differences between these three contrasts were tested for statistical significance.  117 
The contrasts and comparisons were planned a priori and thus no multiple testing 118 
adjustments were required. 119 
  120 
Further characterisation of the EPM carbohydrate was performed after dialysis (14 121 
kDa MWCO) for 72 h at 4oC against three changes of dH2O per day. The EPM was 122 
freeze dried and characterized using NMR spectroscopy (31), monomer analysis 123 
(32) and linkage analysis (33) in comparison with a commercial α-dextran standard 124 
(Sigma-Aldrich).  125 
 126 
Genetic complementation of a cj0511 mutant. A cj0511 mutant obtained from a 127 
collection at the London School of Hygiene and Tropical Medicine (Table 1) was 128 
used to construct a complemented strain by insertion of cj0511 under the control of 129 
the iron-inducible fdxA promoter into a pseudogene (cj0046) in the cj0511 mutant as 130 
previously described (34). The oligonucleotides used are listed in Table 2. 131 
 132 
Production of recombinant Cj0511 and proteolysis assay 133 
Codon optimized cj0511 was synthesized by Celtek, USA and obtained in pGH. The 134 
gene was cut by HindIII (New England Biolabs, UK) and the released DNA fragment 135 
was cloned in pET-28a(+)(Novagen, UK) to generate pMAR31. Expression of cj0511 136 
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was achieved in E.coli BL21 (DE3) (New England Biolabs, UK). To localize the 137 
recombinant protein in the periplasm of E.coli, recombinant Cj0511 was modified to 138 
have a signal peptide from the E.coli DsbA protein fused to the N-terminal, while the 139 
C-terminus was fused to a 6 x-His affinity tag. Recombinant Cj0511 was purified 140 
using nickel affinity column (Qiagen) and eluted in 500 mM imidazole, 300 mM 141 
sodium phosphate and 20 mM sodium chloride buffer. The eluted fractions were 142 
combined and concentrated using an Amicon ultrafiltration column with a 100 kDa 143 
cut off (Merck Millipore, UK) then resuspended in 10 mM sodium phosphate buffer. 144 
One microgram of purified r-Cj0511 was mixed with 2 μg polyhistidine-tagged human 145 
pancreatic amylase (Sino Biologicals) or casein (Sigma Aldrich) in 20 μL of 50 mM 146 
sodium phosphate buffer (pH 7.5) and incubated at 37°C for a total of 2 h. The 147 
reactions were stopped using 6 x Laemmli buffer and the reaction mixtures were 148 
boiled for 10 min before being separated by SDS-PAGE (16% polyacrylamide) and 149 
stained with Coomassie R-250.   150 
 151 
Biofilm assays. A 16 h culture of C. jejuni in BB was diluted to OD600 of 0.1 in BB 152 
with or without 100 nM HPA, 100 nM recombinant human pancreatic amylase or an 153 
equivalent activity of chicken pancreas extract, added to a borosilicate glass tube 154 
(VWR International) and incubated without shaking at 37°C in 5% CO2. After 48 h 155 
the culture was decanted, the biofilms were washed with dH2O, dried and stained for 156 
5 min with 0.1% (w/v) crystal violet (CV; Sigma-Aldrich), washed with dH2O and 157 
dried. Bound CV was solubilised in 80% ethanol-20% acetone and quantified by 158 
measuring OD600. Statistical significance was assessed with a two-sample t-test 159 
assuming unequal variance.  160 
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 161 
Confocal laser scanning microscopy of biofilm. A 16 h culture of C. jejuni was 162 
diluted to OD600 of 0.1 in BB with or without 100 nM HPA and placed in a 6-well 163 
tissue culture plate (Sarstedt). Two glass coverslips were placed upright in each well 164 
and incubated for 48 h at 37°C in 5% CO2. The coverslips were washed in PBS, 165 
stained with Live/Dead BacLight stain (Invitrogen) according to the manufacturer’s 166 
instructions and visualised with a BioRad Radiance 2100 confocal scanning system 167 
attached to an Olympus BX51 upright microscope. Digital images were produced 168 
using Image J software (National Institutes of Health). 169 
   170 
Adhesion and invasion of Caco-2 cells. Human colon cancer cells (Caco-2) were 171 
cultured as previously described (25) and 108 bacteria, grown on MHA with or 172 
without 100 nM HPA, were added at a multiplicity of infection (MOI) of 100:1 and 173 
incubated at 37°C in 5% CO2. Interacting and invading bacteria were enumerated at 174 
3, 6 and 24 h as previously described (25) and statistical significance was assessed 175 
using a two-sample t-test assuming unequal variance. 176 
 177 
Interaction with T84 human colonic epithelial cells. T84 cells were grown in 178 
complete Dulbecco’s Modified Eagle’s Medium Nutrient Mixture F-12 HAM 179 
(Invitrogen) in rat collagen pre-coated transwell dishes until the transepithelial 180 
electrical resistance (TEER) measurement (35) was >800 Ω confirming formation of 181 
tight-junctions in the monolayer. Co-culture studies were performed at a MOI of 10:1 182 
in DMEM/F12 HAM medium containing 10% foetal bovine serum for 6 or 24 h. 183 
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Bacteria were grown on MHA with or without 100 nM HPA and viable counts were 184 
performed. Statistical significance was assessed using a Wilcoxon matched paired 185 
test. IL-8 levels were determined by ELISA (eBioscience) from the supernatant of the 186 
apical surface at 24 h post-infection. Statistical significance was assessed using a 187 
one-way ANOVA. 188 
 189 
Galleria mellonella infection model. G. mellonella larvae were obtained 190 
commercially (Cornish Crispa Co) and stored in containers with wood chips at 12°C. 191 
C. jejuni strains were grown on MHA with or without 100 nM HPA for 48 h, harvested 192 
in PBS and 106 cfu injected into the right foreleg of 10 Galleria larvae as previously 193 
described (36). Statistical significance was assessed using a two-sample t-test, 194 
assuming unequal variance. 195 
 196 
Infection of chickens. Day-old Ross broiler chickens were obtained from a 197 
commercial supplier and housed in biosecure housing. The study was performed 198 
under a project licence issued by the UK Home Office under the Animals (Scientific 199 
Procedures) Act 1986 (PPL 30/2599) and protocols and euthanasia techniques were 200 
approved by the University of Bristol Animal Welfare Ethical Review Board. Birds 201 
were fed commercial starter and grower diets (BOCM Pauls Ltd, Ipswich), had 202 
access to food and water ad libitum and were exposed to a 12 h light/darkness cycle. 203 
At 21 days old, groups of 30 birds were infected by oral gavage with 105 of C. jejuni 204 
11168H or the cj0511 mutant grown on MHA with or without 100 μM HPA for 48 h 205 
and resuspended in MH broth. Fifteen birds were euthanized by cervical dislocation 206 
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at 4 and 7 days post infection and ileum and liver samples removed for culture. Ileum 207 
samples were serially diluted and plated on modified charcoal cefoperazone 208 
deoxycholate agar (mCCDA; Oxoid) incubated at 37oC for 48 h in microaerobic 209 
conditions. Liver samples were homogenised and enriched in modified Exeter broth 210 
(37), incubated with minimal headspace at 37oC for 48 h and plated on mCCDA.  211 
Differences in the number of birds colonised were assessed using a Chi-square test. 212 
The distributions of numbers of bacteria found in samples from the birds were 213 
checked for normality using a D’Agostino and Pearson omnibus normality test; as 214 
data were not shown to follow a Gaussian distribution, differences in the number of 215 
bacteria found at each site were analysed using a Kruskal-Wallis test with Dunn’s 216 
multiple comparison test, using a Benjamini and Hochberg correction to adjust for 217 
multiple pairwise comparisons, as a post-hoc test.  218 
 219 
Resistance to environmental stress. The growth from 48 h MHA plates with and 220 
without 100 nM HPA was recovered into PBS (4°C) or MH broth (20°C), washed and 221 
resuspended to an OD600 of 2.0. The cultures were incubated with shaking (50 rpm) 222 
at 37°C in 5% CO2 and samples were removed at intervals for viable counting.  The 223 
statistical significance of the difference in viable counts in the presence and absence 224 
of HPA was assessed using two sample t-tests, assuming unequal variance.   225 
 226 
RESULTS 227 
C. jejuni responds to the presence of pancreatic amylase. Physiological 228 
concentrations of mammalian pancreatic α-amylase are estimated to be nanomolar 229 
(38). When hog pancreatic α-amylase (HPA) was incorporated into agar at various 230 
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concentrations, we observed the formation of large mucoid colonies of C. jejuni 231 
11168H at a minimum concentration of 100 μM (Fig. 1A). It is important to note that 232 
mucoid colonies were apparent on MHA and also on BA containing 100 μM HPA; 233 
since BA does not contain starch, this indicates that the response is independent of 234 
amylase starch degrading activity. Whilst 100 μM pancreatic amylase seem high 235 
compared to the estimated in vivo concentrations, it is noteworthy that the number of 236 
molecules of amylase that can interact with the bacteria growing on an agar plate is 237 
likely to be low because of spatial confinement, in contrast to physiological 238 
conditions where bacteria will be bathed in litres of pancreatic juice per day.  Mucoid 239 
colonies were also produced by other C. jejuni strains (81-176, 81116, G1, X) in 240 
response to 100 μM HPA but not by the periodontal pathogen, Campylobacter rectus 241 
NCTC 11489 (data not shown).  242 
Pancreatic amylase promotes C. jejuni growth. As the colonies on amylase were 243 
larger in addition to being mucoid, the number of bacteria per colony was determined 244 
for C. jejuni 11168H from HPA-containing (100 μM) and amylase-free MHA. In three 245 
experiments, colonies contained a mean of 5.3 (+/-3.2) x 107 cfu in the presence of 246 
amylase, compared to 3.3 (+/-2.3) x 106 cfu in the absence of amylase, representing 247 
a 16-fold increase. In MEM-α, supplementation with physiological concentrations 248 
(100 nM) of HPA resulted in an increased growth rate (mean generation time of 180 249 
(+/-0) minutes in the presence of pancreatic amylase compared to 280 (+/-35) 250 
minutes in its absence). The difference in growth rate was statistically significant 251 
(p<0.001) at both mid-exponential phase (10 h) and stationary phase (15 h) (Fig. 252 
1B).  253 
 254 
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Mucoid colonies secrete increased amounts of carbohydrate. As mucoid 255 
colonies are suggestive of exo-polysaccharide production, we attempted to purify the 256 
extracellular material from colonies of strain 11168H grown in the presence of 257 
increasing concentrations of HPA by washing in PBS.  Measurement of the 258 
carbohydrate content of this preparation by phenol sulphuric acid assay showed that 259 
exposure to physiological concentrations of HPA (100 nM) resulted in a 100% 260 
increase in the soluble carbohydrate secreted by C. jejuni 11168H compared to 261 
growth without HPA (Fig. 2A). A 11168H kpsM mutant, unable to export CPS (39), 262 
and 11168H waaF and waaC mutants lacking the outer and entire core 263 
oligosaccharide of LOS, respectively (40, 41), also showed increased carbohydrate 264 
secretion of comparable magnitude to the wild-type (WT) strain in the presence of 265 
HPA, indicating that the secreted carbohydrate is independent of both CPS and LOS 266 
(Fig. 2B). The amount of carbohydrate secreted by the 11168H kpsM, waaC and 267 
waaF mutants did not differ significantly from the wild-type strain in either the 268 
presence or absence of pancreatic amylase. 269 
 270 
The secreted carbohydrate is an α-dextran. The soluble extracellular material 271 
recovered from C. jejuni 11168H and the kpsM mutant provided 1H and 13C-NMR 272 
spectra identical to an α-dextran standard (Fig. 2C) and distinct from starch (Fig. 273 
S1). A series of 2D-NMR (COSY, HSQC & HMBC) were also recorded (data not 274 
shown) to confirm the identity of the exo-polysaccharide as an α-dextran. Monomer 275 
analysis was undertaken using high performance anion exchange chromatography in 276 
combination with pulsed amperometric detection.  After acid hydrolysis, the 277 
extracellular material recovered from both C. jejuni 11168H and the kpsM mutant 278 
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gave chromatographs containing a single peak which co-eluted with a glucose 279 
reference standard (Fig. S2). Monomer analysis thus confirmed that glucose was the 280 
only monosaccharide present and linkage analysis showed exclusively 1,6-glycosidic 281 
links (Fig. S3).  282 
 283 
Cj0511 is essential for the response to pancreatic amylase but does not 284 
degrade it in vitro. Since HPA improves the growth of C. jejuni, we reasoned that it 285 
could be degraded by the bacterium. As Cj0511 is a protease (42) that is known to 286 
be secreted in outer membrane vesicles (OMVs) (43) and is abundant in a C. jejuni 287 
strain that colonises chickens efficiently (44), we hypothesized that it is involved in 288 
the response to pancreatic amylase. Determination of the amount of secreted 289 
carbohydrate showed that the increased secretion seen in the WT strain in response 290 
to stimulation with HPA was absent in a cj0511 mutant (Fig. 2D). Restoration of the 291 
response to HPA in the complemented strain (Fig. 2D), shows that the defect in the 292 
cj0511 mutant is the result of inactivation of cj0511 and not due to a polar effect or 293 
spontaneous mutation elsewhere in the genome. To determine if Cj0511 degrades 294 
pancreatic amylase, recombinant Cj0511 (r-Cj0511) was incubated with recombinant 295 
human pancreatic amylase or with casein (Fig. 3). Partial and complete degradation 296 
of casein was apparent at 30 min and 2 h, respectively. In contrast, there was no 297 
apparent degradation of pancreatic amylase after 2 h.  298 
 299 
Exposure to pancreatic amylase promotes biofilm formation. To determine if 300 
exposure to pancreatic amylase contributed to biofilm formation in C. jejuni, biofilms 301 
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formed at the air/liquid interface in glass tubes in the presence or absence of 302 
physiological concentrations of pancreatic amylase (100 nM) were measured by 303 
crystal violet staining. With the exception of the cj0511 mutant, all the strains showed 304 
significant increases in biofilm formation in the presence of HPA (Fig. 4A). The 305 
magnitude of the increase in biofilm in response to HPA in the waaC, waaF and 306 
kpsM mutants was similar to the WT (2.1-2.5-fold) demonstrating that it is 307 
independent of LOS and CPS. Although we observed increased biofilm formation by 308 
the cj0511 mutant compared to the WT in the absence of HPA (p=0.003), there was 309 
no significant increase in the presence of HPA in this mutant (in contrast with the 310 
complemented strain), demonstrating that a functional Cj0511 protease is required 311 
for the response (Fig. 4A). To confirm that the increased biofilm was specifically due 312 
to pancreatic amylase, the assay was repeated in the presence of 100 nM 313 
recombinant human pancreatic amylase and an increase in biofilm density of similar 314 
magnitude (2.2-fold; p=0.001) to that obtained with the preparation of HPA was 315 
observed (Fig. 4B). Addition of a volume of chicken pancreas extract containing 316 
equivalent amylase activity also resulted in an increase in biofilm density (2.2-fold; 317 
p<0.001) (Fig. 4C).  318 
 Confocal laser scanning microscopy (CLSM) was used to visualise biofilms of 319 
C. jejuni 11168H grown in the presence or absence of HPA. In the presence of HPA 320 
there was typical biofilm structure at 48 h with adherent microcolonies of live bacteria 321 
separated by dark channels, whereas there were few adherent bacteria in the 322 
absence of HPA (Fig. 4D).  Examination in the x-z plane showed typical three-323 
dimensional biofilm structure (of maximum height 160 μm) only in the presence of 324 
HPA. 325 
15 
 
 326 
Pre-exposure to pancreatic amylase promotes interaction with human IECs. To 327 
determine if pre-exposure of C. jejuni to HPA affects the interaction with IECs, 328 
strains grown with or without 100 nM HPA were co-cultured with Caco-2 cells. C. 329 
jejuni 11168H grown in the presence of HPA showed significant increases in the 330 
number of interacting bacteria after 3, 6 and 24 h of co-culture (Fig. 5A). Growth of 331 
C. jejuni 81-176 in the presence of HPA also resulted in significant increases in 332 
interaction with Caco-2 cells (data not shown). In contrast, exposure of the C. jejuni 333 
11168H cj0511 mutant to HPA did not result in increased interaction, whereas the 334 
complemented strain did show significant increases (Fig. 5A). Pre-exposure to HPA 335 
also resulted in increased invasion by strains 11168H (Fig. 5B) and 81-176 (data not 336 
shown). There was no increase in invasion by the cj0511 mutant with pre-exposure 337 
to HPA whereas the complemented strain showed a significant increase (Fig. 5B). 338 
 To explore the effect of pre-exposure to HPA on IEC cytokine responses, we 339 
measured interleukin-8 (IL-8) secretion from T84 human colon cancer cells in 340 
response to bacteria grown with or without HPA. At 24 h, we observed a significant 341 
increase in IL-8 secretion in response to infection but growth on HPA had no effect 342 
(Fig. 5C).  A similar lack of cytokine response to HPA pre-treatment was observed in 343 
THP-1 macrophages (data not shown). The effect of infection on transepithelial 344 
electrical resistance (TEER) was also investigated. No disruption in tight-junction 345 
integrity in response to C. jejuni grown on HPA was noted 6 h post-infection (data 346 
not shown), but there was a significant increase in translocation of the bacteria pre-347 
exposed to HPA compared to those grown without HPA (Fig. 5D), a difference no 348 
longer apparent at 24 h (data not shown). 349 
 350 
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Pre-exposure to pancreatic amylase results in increased killing of Galleria 351 
mellonella larvae. C. jejuni 11168H, 81-176 and the cj0511 and kpsM mutants were 352 
grown with or without HPA, injected into ten G. mellonella larvae and the number of 353 
dead larvae determined at 24 h (Fig. 6). For both WT strains, a mean of 1 - 2 larvae 354 
were killed when the bacteria were grown without HPA compared to means of ~9 355 
when grown with HPA. The increased virulence in response to HPA was lost in the 356 
cj0511 mutant but restored in the complemented strain (Fig. 6), confirming the 357 
essential role of Cj0511 in signal detection.  358 
 359 
Pre-exposure to pancreatic amylase promotes colonisation of broiler chickens. 360 
To determine whether pre-exposure to pancreatic amylase affects the ability of C. 361 
jejuni to colonise chickens, strain 11168H and the cj0511 mutant grown with or 362 
without HPA were used to infect broiler chickens of 21 days old. At day 4, the WT 363 
strain had colonised better than the cj0511 mutant, but no difference was apparent 364 
between treatments (Fig. 7A).  By day 7, the number of birds colonised by the WT 365 
strain exposed to HPA prior to infection was significantly greater than the number of 366 
birds colonised by this strain not exposed to HPA (p=0.005) (Fig. 7B). Differences in 367 
the numbers of bacteria present between infection groups were seen at day 4 368 
(p=0.0006; Kruskal-Wallis test) and day 7 (p=0.0026). At day 4 in chickens infected 369 
with strains grown in the presence of HPA the WT strain was present in significantly 370 
higher numbers in the ileum (13/15 birds infected, median 3.0x104 cfu/g, range 0-371 
1.5x105 cfu/g) compared to the cj0511 mutant (5/15 birds infected, median 0 cfu/g, 372 
range 0-1.5x104 cfu/g) (Fig. 7C). Growth on HPA also significantly increased the 373 
numbers of the WT strain in the ileum at day 7 (11/15 birds infected, median 2.0x104 374 
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cfu/g, range 0-3x104 cfu/g) compared to the unexposed WT (5/15 birds infected, 375 
median 0 cfu/g, range 0-3x104 cfu/g), whereas there was no such increase 376 
detectable in the cj0511 mutant (Fig. 7D).  377 
 378 
Pre-exposure to pancreatic amylase promotes survival in stress environments. 379 
To assess the role of the α-dextran in survival outside the host, we cultured C. jejuni 380 
11168H in the presence or absence of 100 nM HPA, recovered the bacteria into 381 
either broth or PBS without HPA and determined by viable counting the numbers of 382 
surviving bacteria at room temperature and at 4ºC in air.  In both stress conditions, 383 
pre-exposure to HPA prolonged survival suggesting that the α-dextran has a 384 
protective effect (Fig. 8).  385 
 386 
DISCUSSION 387 
Given that C. jejuni has been described as a “sugary bug” (45) it is somewhat 388 
surprising that until the work described herein, no definitive identification of a 389 
polysaccharide involved in biofilm formation had been made. Indeed it has been 390 
suggested that DNA is a major component of the C. jejuni biofilm matrix (26). 391 
However, when C. jejuni is freshly isolated from animal or human stools it is highly 392 
mucoid (Allan, unpublished observation), suggesting that a polysaccharide matrix is 393 
being produced. This led us to hypothesize that a host factor was responsible for 394 
inducing the polysaccharide EPM.  Such interkingdom signalling between eukaryotes 395 
and prokaryotes was first identified over a century ago (46). Over the last decade or 396 
so it has been established that interkingdom signalling between bacteria and hosts, 397 
via “hormones” is widespread (47). One of the first reports of this was the effect of 398 
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adrenaline and noradrenaline on E. coli (48). There are a limited number of reports 399 
on host cell molecules affecting biofilm formation by bacteria. For example, bile salts 400 
enhance biofilm formation by C. jejuni (26), Listeria monocytogenes (49) and Vibrio 401 
cholerae (50). In the case of Streptococcus pneumonia, a number of host factors 402 
affect biofilm formation and structure including norepinephrine (51), and 403 
extracytoplasmic ATP (52). Our work shows for the first time that avian and 404 
mammalian pancreatic amylase can act as an interkingdom signalling molecule and 405 
enhance C. jejuni growth and biofilm formation. It is important to emphasise that a 406 
mucoid colony is produced on Brucella agar in response to pancreatic amylase. This 407 
medium does not contain starch, indicating that the response is directly to the 408 
presence of amylase protein and is not dependent on amylase starch degrading 409 
activity. This was confirmed in the biofilm assay which was also carried out in 410 
medium lacking starch.  To our knowledge this is only the second example of a 411 
proteinaceous host component that can enhance bacterial biofilm formation, the first 412 
being the cytokine interleukin 1β which enhances biofilm formation by 413 
Staphylococcus aureus (53). Interestingly, C. rectus did not appear to detect 414 
pancreatic amylase suggesting that the response may be a specific adaptation to 415 
host environments. It will be interesting to investigate in future work whether the 416 
enteric and oral Campylobacter spp. are able to detect the presence of salivary 417 
amylase, given its similarity in sequence and structure to pancreatic amylase.  418 
 419 
The polysaccharide secreted by C. jejuni was definitively identified as  α-dextran and 420 
the ease with which it was removed from the bacterial cell surface, by simply 421 
washing in saline, indicates that it is a loosely-associated ‘slime polysaccharide’ as 422 
oppose to the capsular polysaccharides that are covalently attached to the cell wall 423 
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(16, 54). Given that C. jejuni is capable of producing complex glycan structures (18), 424 
the production of a simple α-dextran is intriguing. Dextrans are produced by oral 425 
streptococci and Leuconostoc spp. from sucrose using dextransucrases, cell wall-426 
anchored enzymes of the glycoside hydrolase superfamily (56). Searching the 427 
translated C. jejuni genome sequences with known dextransucrase sequences did 428 
not identify homologues, suggesting that dextran synthesis in C. jejuni occurs by a 429 
novel mechanism. The source of the glucose monomer, whether it is taken up from 430 
the environment or synthesized from amino acids, awaits experimental investigation.  431 
  432 
The fact that HPA enhances the growth of C. jejuni suggested that it may be used as 433 
a nutrient source and Cj0511, predicted as a serine protease of the C-terminal 434 
protease (CTP) family and known to be secreted in OMVs (43), seemed a likely 435 
candidate for degrading pancreatic amylase.  Our data shows that a cj0511 mutant 436 
did not display the response to HPA, a phenotype that was restored in a 437 
complemented strain, confirming the role of Cj0511 specifically. However, there was 438 
no apparent change in migration of recombinant human amylase on an SDS-PAGE 439 
gel following incubation with Cj0511 even though partial casein degradation was 440 
apparent in 30 min and complete digestion in 2 h. The recombinant amylase is 441 
tagged with 6 histidine residues at the C-terminus and C-terminal proteolysis of even 442 
a single amino acid would result in a reduction of ~1 kDa in the molecular weight of 443 
the protein which would be apparent on a 16% polyacrylamide gel. In this context, it 444 
is important to emphasise that the polyhistidine-tagged human recombinant amylase 445 
preparation was active, since we showed it induced biofilm formation in the wild-type 446 
strain. Thus, interference by the polyhistidine tag cannot explain why we fail to see 447 
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cleavage by r-Cj0511 in vitro. Since Cj0511 is N-glycosylated in C. jejuni (Young et 448 
al., 2002), an absence of glycosylation in r-Cj0511 is another plausible explanation. 449 
However, we have shown that a pglB mutant (i.e. defective for N-glycosylation; 55) 450 
still responds to pancreatic amylase (Jowiya and Allan, unpublished), which 451 
discounts this explanation also. Thus we conclude that Cj0511 does not digest 452 
pancreatic amylase, at least in vitro. Bacterial CTPs are involved in a range of 453 
physiological processes. The Escherichia coli tail-specific protease processes 454 
penicillin binding proteins and regulates cell morphology (57).  CTPs with roles in 455 
virulence have also been described: for example, CtpA of Brucella suis is required 456 
for virulence in a mouse infection model (58). A recent study by Karlyshev and co-457 
workers showed that a cj0511 mutant was severely attenuated in its ability to 458 
colonise chickens (42). Since Cj0511 does not appear to degrade pancreatic 459 
amylase, we conclude that it is involved at a later stage in the molecular mechanism; 460 
elucidation of its precise role requires further research. Previous studies have shown 461 
that Cj0511 is expressed in the absence of pancreatic amylase (43) suggesting that 462 
its expression is constitutive. It will be interesting in future work to see if Cj0511 463 
levels are increased in the presence of pancreatic amylase.  464 
  465 
Having established that pancreatic amylase induces secretion of an α-dextran, we 466 
next addressed the biological consequence. Growth on physiological concentrations 467 
of HPA resulted in increased biofilm formation in two different WT strains. Moreover, 468 
the increase in biofilm formation induced by HPA was dependent on Cj0511. Since 469 
the purity of the commercial HPA preparation is not guaranteed, we tested purified 470 
recombinant human pancreatic amylase in the biofilm assay and observed an 471 
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increase in biofilm formation of similar magnitude to that induced by HPA, confirming 472 
that the response is to pancreatic amylase specifically. Biofilm formation was also 473 
increased in response to an extract of chicken pancreas suggesting that the α-474 
dextran promotes biofilm formation in the intestines of both mammalian and avian 475 
hosts.  476 
 The study next investigated the effect of HPA exposure on the interaction of 477 
C. jejuni with IECs. Growth on HPA resulted in a significant increase in adhesion and 478 
invasion of C. jejuni in Caco-2 cells. As the neutrophil chemoattractant IL-8 has a 479 
role in the response to C. jejuni (59), we studied production by T84 cells as they are 480 
more potent cytokine responders than Caco-2 cells (60). Surprisingly, no difference 481 
in IL-8 secretion in response to bacteria grown with or without HPA was observed. 482 
Pre-exposure to HPA led to a significant increase in bacterial translocation 6 h post-483 
infection, however, without loss of tight junction integrity. Collectively, these data 484 
suggest that the α-dextran modulates early host-pathogen interactions by promoting 485 
rapid intracellular transfer while avoiding overt host inflammatory responses. It is 486 
intriguing to speculate that an α-1,6-dextran evolved as a colonisation factor since it 487 
exhibits sufficient similarity to dietary starch to be tolerated by the immune system 488 
yet is resistant to the α-1,4-glucan glucanohydrolase activity of pancreatic amylase. 489 
 In the G. mellonella infection model, growth of C. jejuni on pancreatic amylase 490 
resulted in increased virulence and this is again dependent on Cj0511. G. mellonella 491 
larvae have been used as a model to study infection by C. jejuni (36) and other 492 
enteric pathogens as they possess both humoral and cellular immune systems (61). 493 
The increased insecticidal activity of C. jejuni grown on HPA suggests that biofilm 494 
formation may contribute to resistance to these immune mechanisms. It is notable 495 
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that the insecticidal activity observed for C. jejuni 11168H and 81-176 in the absence 496 
of pancreatic amylase was lower than that reported by Champion et al. (36) for these 497 
strains. We assume that the decreased virulence observed in our study is a 498 
reflection of culture on Mueller Hinton agar as oppose to Columbia blood agar which 499 
was used by Champion et al. 500 
  501 
 In the laboratory, C. jejuni is sensitive to environmental stresses such as 502 
drying, chilling, and exposure to atmospheric oxygen yet the bacterium exhibits a 503 
remarkable ability to persist in food processing facilities and natural environments 504 
(62). We have shown that pre-exposure of C. jejuni to pancreatic amylase prolongs 505 
survival in atmospheric conditions at ambient and refrigeration temperatures. This 506 
demonstrates that the α-dextran, which will be expressed by C. jejuni expelled into 507 
the environment from a host organism, is stable and may be important for the 508 
environmental resilience of the bacterium.  509 
 In conclusion, we propose a new model in which C. jejuni uses host 510 
pancreatic amylase, encountered as it passes the pancreatic duct, as a signal for 511 
secretion of an α-dextran which promotes biofilm formation and contributes to 512 
colonisation of the mammalian and avian intestine and increases resistance to host 513 
immune functions. We have shown that Cj0511, a secreted serine protease, is 514 
required for the response to pancreatic amylase although its precise function in the 515 
response is currently unknown. The demonstration of a secreted dextran that leads 516 
to biofilm formation is an important finding that is expected to enable the design of 517 
intervention strategies to reduce the burden of C. jejuni in the food chain and 518 
ultimately to reduce the incidence of human enteric disease.  519 
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Table 1. Bacterial strains and plasmids 752 
 753 
Bacterial strain Characteristics                 Reference 
C. jejuni 11168H Hyper-motile variant of NCTC 
11168; good coloniser of 
chickens  
(63) 
 
C. jejuni 81-176 Clinical isolate from human 
diarrhoea sample 
(64) 
C. jejuni 81116 Waterborne human outbreak 
strain 
(65) 
C. jejuni X Clinical isolate from patient with 
enteritis 
(66) 
C. jejuni G1 Clinical isolate from patient with 
Guillain-Barré syndrome  
(67) 
C. jejuni 11168H kpsM::aphA3 Mutant in gene encoding ABC 
transporter involved in capsule 
assembly; no CPS expression 
(68) 
 
C. jejuni 11168H waaC::aphA3 Mutant in gene encoding 
heptosyltransferase I; 
expresses truncated LOS 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
C. jejuni 11168H waaF::aphA3 Mutant in gene encoding 
heptosyltransferase II: 
expresses truncated core 
oligosaccharide 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
C. jejuni 11168H cj0511::aphA3 
 
Mutant in gene encoding 
secreted carboxyl-terminal 
protease. 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
11168H cj0511::aphA3 pWJ4 Complemented strain 
containing cj0511 gene and  
Camr inserted into cj0046 
This study 
C. rectus NCTC 11489 Type strain, from human 
periodontal pocket 
Public Health England culture 
collections 
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E. coli JM109 Cloning host                      Promega 
E.coli BL21 (DE3) Expression host New England Biolabs 
Plasmid   
pJMK30  pUC19 carrying C. coli Kanr  
gene aphA-3 
(69) 
 
pGEM-T-Easy Cloning vector enables TA 
cloning 
Promega 
pC46fdxA 
 
Complementation vector 
containing fdxA promoter, Camr 
selection marker. 
(34) 
 754 
  755 
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Table 2. Oligonucleotides 756 
 757 
Name Sequence (5’-3’)                  Use 
WJ10F GTCGTCTCACATGTTGAAAACAAAACG Amplification of cj0511 for cloning 
in pC46fdxA (BsmBI site 
underlined) 
WJ10R GTCGTCTCACATGTTATTGTCCTTGTTTG Amplification of cj0511 for cloning 
in pC46fdxA (BsmBI site 
underlined) 
WJ4 GTAAATTTTTGATTATCAAAATTTACATTATTTAAG Orientation of cj0511 with respect 
to PfdxA in pC46fdxA; anneals in 
PfdxA 
WJ11 GGAACACAGCAGAGCACTTG Confirmation of cj0511 
complementing strain; anneals in 
cjs03 RNA coding sequence 
located 5’ to cj0046 
WJ12 CCTGGAGAAGTATTAGATAGTAGCG Confirmation of cj0511 
complementing strain; anneals in 
cj0053c located 3’ to cj0046  
 758 
  759 
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FIG. 1. Exposure to pancreatic amylase promotes growth and results in a large, 760 
mucoid colony. A. C. jejuni 11168H grown at 37°C for 72 h on BA containing 0.4% 761 
charcoal without (left) or with (right) 100 μM HPA. The ruler marks 5 mm intervals. B. 762 
C. jejuni 11168H growth with shaking (50 rpm) in 5% CO2 at 37°C in MEM-α with 763 
(squares) or without (diamonds) 100 nM HPA. Data reported as means and standard 764 
deviations (SD) from three independent experiments. The statistical significance of 765 
the difference in growth in the presence and absence of HPA was assessed at two 766 
time points (10 and 15 h) using a two-sample t-test, assuming unequal variance; 767 
***p<0.001. 768 
 769 
FIG. 2. Physiological concentrations of pancreatic amylase induces α-dextran 770 
secretion in C. jejuni and the secreted protease, Cj0511 is required. (A) Total 771 
extracellular carbohydrate in C. jejuni 11168H grown in the presence of increasing 772 
concentrations of HPA. Data reported as mean and standard deviation from three 773 
experiments (p<0.0001 for the contrast between the three lowest doses and the four 774 
highest doses of pancreatic amylase; p<0.0001 for the contrast between 50 mM and 775 
100 nM pancreatic amylase within one-way ANOVA). (B) Total extracellular 776 
carbohydrate in different C. jejuni strains grown in the presence (black bars) or 777 
absence (white bars) of 100 nM HPA. Data reported as mean and standard deviation 778 
from three experiments. The kpsM, waaC and waaF mutants were created in strain 779 
11168H. Asterisks indicate statistically significant increases in the presence of HPA 780 
determined by a two-sample t test; ***p<0.001, **p<0.01, *p<0.05. (C) 1H-NMR 781 
spectra of extracellular material from C. jejuni 11168H, a kpsM mutant and a 782 
commercial α-dextran recorded in D20 at 7oC using acetone as an internal standard 783 
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on a Bruker Avance 400 MHz spectrometer. (D) Total extracellular carbohydrate in 784 
C. jejuni 11168H (black bars), a Cj0511 mutant (white bars) and a Cj0511 785 
complemented strain (grey bars) grown on MHA with increasing concentrations of 786 
HPA. A two-way ANOVA showed that the interaction between the bacterial strain 787 
and the dose of pancreatic amylase was highly significant (p<0.0001). The contrasts 788 
comparing the pattern of the response between the wild-type strain and the Cj0511 789 
mutant and between the mutant and the complemented strain were both statistically 790 
significant (p<0.0001).  791 
 792 
Fig. 3. Proteolysis of casein and pancreatic amylase by r-Cj0511. Coomassie-793 
stained SDS-polyacrylamide gel showing no detectable proteolysis of polyhistidine 794 
tagged human pancreatic amylase. Casein served as a positive control.   795 
 796 
Fig. 4. Exposure to pancreatic amylase promotes biofilm formation. (A) Biofilm 797 
formation at 48 h by C. jejuni strains on glass tubes in the presence (black bars) or 798 
absence (white bars) of 100 nM HPA. Data reported as means and SD from three 799 
independent experiments. Asterisks indicate statistically significant increases in the 800 
presence of HPA; ***p<0.0001. (B) Biofilm formation at 48 h by C. jejuni 11168H on 801 
glass tubes in the presence (black bars) or absence (white bars) of 100 nM 802 
recombinant human amylase. Data reported as mean +/- SD from three independent 803 
experiments. Asterisks indicate statistically significant increases in the presence of 804 
pancreatic amylase; ***p<0.001. (C) Biofilm formation at 48 h by C. jejuni 11168H on 805 
glass tubes in the presence (black bars) or absence (white bars) of chicken pancreas 806 
extract. Data reported as mean +/- SD from three independent experiments. 807 
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Asterisks indicate statistically significant increases in the presence of pancreatic 808 
amylase; ***p<0.001. (D) CLSM of Live/Dead stained C. jejuni 11168H biofilm at 48 809 
h. Top panels, confocal images of bacteria in x-y plane, bottom panels, digital 810 
images in x-z plane. 811 
 812 
FIG. 5. Pre-exposure to pancreatic amylase promotes interaction with human 813 
intestinal epithelial cells. (A) Interaction with Caco-2 cells by C. jejuni 11168H 814 
grown in the presence (black bars) or absence (white bars) of 100 nM HPA. Bacteria 815 
were co-cultured with Caco-2 cells for 3, 6 and 24 h. (B) Invasion of Caco-2 cells by 816 
C. jejuni 11168H grown in the presence (black bars) or absence (white bars) of 100 817 
nM HPA. (C) Apical IL-8 levels in T84 cells at 24 h in response to C. jejuni 11168H, 818 
the Cj0511 mutant and the complemented strain grown in the presence (black bars) 819 
and absence (white bars) of 100 nM HPA. (D) Translocation of C. jejuni in T84 cells 820 
at 6 h. C. jejuni 11168H, a Cj0511 mutant and a complemented strain were grown in 821 
the presence (black bars) and absence (white bars) of 100 nM HPA. For (A) to (C), 822 
data reported as mean +/- SD from three independent experiments. For (C), analysis 823 
by one-way ANOVA showed that there was a significant increase in IL-8 secretion in 824 
response to infection (p<0.05); the construction of contrasts within ANOVA showed 825 
that there was no significant increase in the levels of IL-8 in response to any of the 826 
bacterial strains grown with pancreatic amylase compared to the same bacteria 827 
grown in its absence (p>0.05). For (D), data reported as mean +/- SD from three 828 
independent experiments for C. jejuni 11168H and the cj0511 mutant. For the cj0511 829 
complemented strain, the mean +/- SD from two independent experiments is 830 
reported as a result of contamination in the third experiment, thus no statistical 831 
analysis is presented. ***p<0.0001, *p<0.05. 832 
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 833 
FIG. 6. Pre-exposure to pancreatic amylase promotes infection of Galleria 834 
mellonella larvae. Killing of G. mellonella larvae by C. jejuni grown in the presence 835 
(black bars) or absence (white bars) of 100 nM HPA. 10 larvae were infected with 836 
each strain or with PBS alone. Injection with PBS did not kill any larvae. The kpsM 837 
mutant and the cj0511 mutant and complemented strain were derived from C. jejuni 838 
11168H. Data reported as mean and SD from three independent experiments. 839 
Asterisks indicate statistically significant increases in the presence of HPA; 840 
**p=0.001. 841 
 842 
FIG. 7. Pre-exposure to pancreatic amylase promotes colonisation of broiler 843 
chickens. (A) and (B) number of birds from which Campylobacter was isolated from 844 
the ileum at 4 d and 7 d post infection, respectively. C. jejuni was grown with (black 845 
bars) or without HPA (white bars). n=15 birds per group. By day 7, exposure of the 846 
WT strain to HPA prior to infection resulted in infection in a greater number of 847 
chickens (p=0.005; indicated by bar). (C) and (D) cfu of Campylobacter per gram of 848 
ileal contents in birds 4 d and 7 d post infection, respectively. Open symbols show 849 
strains grown without HPA, closed symbols show strains grown with HPA. Significant 850 
differences were seen between groups on days 4 (C; P=0.0006) and 7 (D; 851 
P=0.0026) by Kruskal-Wallis test. Bars indicate groups between which differences 852 
occur assessed by Dunn’s multiple comparison test. n=15 birds per group.   853 
 854 
FIG. 8. Pre-exposure to pancreatic amylase promotes survival in stress 855 
environments. (A). Survival at 4°C of C. jejuni 11168H grown with (squares) or 856 
40 
 
without (diamonds) HPA. (B). Survival at 20°C in air of C. jejuni 11168H grown with 857 
(squares) or without (diamonds) HPA. Data reported as means +/- SD from three 858 
independent experiments. Statistical significance between the counts in the 859 
presence and absence of HPA was assessed using a two-sample t-test, assuming 860 
unequal variance; **p<0.01, ***p<0.001. 861 
 862 
 863 
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